维普中文期刊产品整合服务
19篇 您的检索式:作者名="KREMPF M"
    题名 作者 年代 出处 被引量
1Efficacy and safety of alirocumab in reducing lipids and cardiovascular events显示文摘Robinson JG Farnier M Krempf M 2015N Engl J Med2015,372,16:1
2Cardiovascularevent rates in diabetic and nondiabetic individuals with andwithout established atherothrombosis(from the Reduction ofAtherothrombosis for Continued Health Registry)显示文摘Krempf M Parhofer K G Steg P G 2010Am J Cardiol2010,105,5:1
3Use of m- in- odobenzylguanidine in the treatment of malignant pheochromcyto- ma显示文摘Krempf M Lumbroso J Mornex R 1991J Clin Endocrinol Metab1991,72,9:1
4D and ^18O enrichment measurements in biological fluids in a continuous-flow elemental analyzer with an isotope-ratio mass spectrometer using two configurations 显示文摘Ripoche N Ferchaud-Roucher V Krempf M Ritz P 2006J Mass Spectrom2006,41,:1
5D and (18)O enrichment measurements in biological fluids in a continuous-flow elemental analyser with an isotope-ratio mass spectrometer using two configurations显示文摘Ripoche N Ferchaud-Roucher V Krempf M 0,,09:1
6Efficacy and safety of a1irocumab in reducing lipids and cardiovascular events显示文摘Robinson JG Farnier M Krempf M 2015N Engl J Med2015,372,6:1
7D and ^18O enrichment measurements in biological fluids in a continuous-flow elemental analyser with an isotope-ratio mass spectrometer using two configurations显示文摘Ripoche N Ferchaud-Roucher V Krempf M 2006Journal of mass spectrometry2006,41,9:1
8Efficacy andsafety of alirocumab in reducing lipids and cardiovascularevents 显示文摘Robinson JG Farnier M Krempf M 2015N Engl J Med2015,372,16:1
9Efficacy and safety of alirocumab in reducing lipids and cardiovascular events显示文摘ROBINSON JG FARNIER M KREMPF M 2015N Engl J Med2015,372,16:1
10Efficacy and safety of alirocumab in reducing lipids and cardiovascular events显示文摘ROBINSON J G FARNIER M KREMPF M 2015N Engl J Med2015,322,:1
11Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events显示文摘ROBINSON J G FARNIER M KREMPF M 2015N Engl J Med2015,372,:1
12Efficacy and safety of alirocumab in reducing lipids and cardiovascular events显示文摘Robinson JG Farnier M Krempf M 2015N Engl J Med2015,372,16:1
13PCSK9 and LDL cholesterol: unravelling the target to design the bullet 显示文摘Costet P Krempf M Cariou B 2008Trends Biochem Sci2008,33,9:1
14显示文摘Ranganathan S Krempf M Feraille E 1993Diabetes Metab1993,19,:1
15Efficacy and safety of alirocumab in reducing lipids and cardiovascular events显示文摘Robinson JG Farnier M Krempf M 2015N Engl J Med2015,372,16:1
16Omega 3 fatty acids pro- mote macrophage reverse cholesterol translport in hamster fed high fat diet显示文摘Kasbi Chadli F Nazih H Krempf M 2013Plos One2013,8,61:1
17Efficacy and safety of alirocumab in reducing lipids and cardiovascular events显示文摘ROBINSON J G FARNIER M KREMPF M 2015N Engl J Med2015,372,:1
18Efficacy and safety of Alirocumab in reducing lipids and cardiovascular events 显示文摘Robinson JG Farnier M Krempf M 2015N Engl J Med2015,372,16:1
19Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health Registry) 显示文摘Krempf M Parhofer K G Steg P G 2010Am J Cardiol2010,105,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费